Evaluation of the Efficacy of Intense Pulse Light Combined With Lipiflow in the Treatment of Meibomian Gland Dysfunction
NCT ID: NCT04633798
Last Updated: 2020-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2020-12-01
2020-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IPL/Lipiflow
the group in which patients treated with IPL combined with lipiflow
IPL/Lipiflow
To treat patients with MGD using intense pulsed light combined with lipiflow
IPL/MGX
the group in which patients treated with IPL combined with meibomian gland massage
IPL/MGX
To treat patients with MGD using intense pulsed light combined with meibomian gland massage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IPL/Lipiflow
To treat patients with MGD using intense pulsed light combined with lipiflow
IPL/MGX
To treat patients with MGD using intense pulsed light combined with meibomian gland massage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with ocular discomfort
* skin type:FitzpatricⅠ-Ⅳ
Exclusion Criteria
* eye surgery history in the last 12 months
* patients who have received IPL or Lipiflow in the last 12 months
* patients who wear contact lens in last one month
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aier School of Ophthalmology, Central South University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Chen, doctor
Role: PRINCIPAL_INVESTIGATOR
Shanghai aier eys hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHAIER2020IRB04
Identifier Type: -
Identifier Source: org_study_id